Lord's Mark Industries Forges Partnership with CMET for Revolutionary Breast Cancer Screening Device
Lord's Mark Industries Limited has entered into a significant Technology Transfer Agreement with the Centre for Materials for Electronic Technology (CMET) to develop and manufacture an innovative AI-powered, radiation-free Breast Screening Wearable Device. This collaboration aims to enhance early detection of breast cancer through advanced, non-invasive technology.
Addressing a Critical Health Challenge in India
India holds the third position globally in new breast cancer incidence rates, following China and the United States. Breast cancer constitutes over 26% of all female cancers in the country, highlighting an urgent need for improved screening solutions. The global breast cancer market was valued at approximately USD 4,882.14 million in 2024, with projections indicating growth to USD 12,880.85 million by 2035, reflecting a compound annual growth rate of 9.22%.
Market analyses underscore the importance of diagnostics in this sector. Grand View Research identifies diagnostics as the dominant segment, driven by increasing demand for early detection. Meanwhile, Future Market Insights estimates the screening and diagnostics market to be between USD 5.05 billion and USD 5.86 billion in 2025, with expectations to reach USD 10.5 billion to USD 11.36 billion by 2033-2035.
Innovative Technology and Key Features
The wearable device integrates high-precision thermal sensors with AI-driven temperature mapping to identify early-stage abnormalities without radiation or invasive procedures. This partnership leverages CMET's research and development expertise alongside Lord's Mark's manufacturing capabilities and distribution network, accelerating indigenous medical technology innovation.
Key advantages of the device include:
- Convenience and Minimal Infrastructure: Designed for use in comfortable settings such as hospitals, clinics, community centers, and homes with minimal setup requirements.
- Non-Radiative and Painless: Eliminates radiation exposure and discomfort, potentially improving screening compliance among women.
- Advanced Thermal Sensors: Utilizes high-precision temperature mapping powered by AI analytics to provide real-time insights.
- Privacy-First Design: Discreetly wearable under clothing, ensuring user dignity and comfort.
- Early Abnormality Detection: Identifies thermal irregularities at early stages to facilitate timely medical evaluation.
- Portability and Scalability: Lightweight and mobile, enabling deployment across both urban and underserved regions.
A Significant Advancement Over Traditional Methods
This device represents a notable improvement over conventional mammography by removing radiation risks and discomfort, extending access beyond hospital environments, and delivering reliable AI-driven detection insights. Lord's Mark reinforces its commitment to advancing accessible, AI-led healthcare solutions, positioning itself at the forefront of scalable preventive diagnostics in India.
Leadership Perspective and Strategic Vision
Sachidanand Upadhyay, Managing Director of Lord's Mark Industries Limited, commented on the collaboration: "This partnership marks a defining step in our journey to build globally competitive, indigenous healthcare technologies. By integrating CMET's scientific expertise with Lord's Mark's manufacturing strength, we are enabling a new paradigm in preventive diagnostics—non-invasive, AI-driven, and truly accessible. Our vision is to reduce barriers to early detection and empower women across India with safer, smarter screening solutions. This is not just a product initiative; it is a commitment to scalable, impact-led healthcare innovation."
With this initiative, Lord's Mark aims to strengthen its focus on technology-driven healthcare manufacturing, emphasizing intelligent, inclusive, and impact-driven solutions to make early detection safer, simpler, and more accessible. The company plans to commercialize the product for large-scale breast cancer screening in India and subsequently expand to international markets through its global network. This effort aligns with a broader ambition to promote India-developed healthcare technology worldwide.
Affordability and Awareness Goals
Lord's Mark intends to make the screening solution affordable, enhancing access for women in India and abroad to regular testing. The initiative also seeks to support greater awareness about breast cancer and highlight the critical role of early detection in improving treatment outcomes. The company anticipates the product will be available for commercial use globally by the end of the year.
